GAM
MDGL icon

Groupama Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Groupama Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4M Buy
35,238
+4,618
+15% +$2.21M 0.27% 66
2025
Q4 		$17.8M Buy
30,620
+3,176
+12% +$1.62M 0.26% 67
2025
Q3 		$12.6M Sell
27,444
-13,447
-33% -$5.02M 0.18% 72
2025
Q2 		$12.3M Buy
40,891
+7,439
+22% +$2.22M 0.2% 74
2025
Q1 		$11M Buy
33,452
+9,128
+38% +$3M 0.22% 73
2024
Q4 		$7.58M Buy
24,324
+11,487
+89% +$3.23M 0.15% 87
2024
Q3 		$2.19M Buy
12,837
+963
+8% +$246K 0.06% 169
2024
Q2 		$3.33M Buy
11,874
+11,659
+5,423% +$2.78M 0.05% 152
2024
Q1 		$3.02M Sell
215
-8,814
-98% -$2.08M 0.06% 185
2023
Q4 		$2.09M Buy
+9,029
New +$1.58M 0.05% 202

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Groupama Asset Management's MDGL Position: Q1 2026 in Review

Groupama Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 15% in Q1 2026, buying an estimated $2.21M and bringing the position to 35,238 shares worth $18.4M. The position accounts for 0.27% of the portfolio, ranked #66.

Groupama Asset Management first reported a position in MDGL in Q4 2023 and has held it in 10 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Groupama Asset Management held 35,238 shares of Madrigal Pharmaceuticals worth $18.4M as of Q1 2026.
  • Groupama Asset Management bought 4,618 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $2.21M.
  • Madrigal Pharmaceuticals made up 0.27% of Groupama Asset Management's portfolio in Q1 2026, its #66 holding.
  • Groupama Asset Management first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Groupama Asset Management's 13F filing for Q1 2026, filed 22 May 2026.